News
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to ...
To date, the Company has not received any reports of adverse events related to this recall. Pfizer is voluntarily recalling 4 additional lots of its smoking cessation therapy Chantix (varenicline ...
Varenicline is available in 0.5- and 1-mg tablets. The labeling information recommends adjusting the dosage from 0.5 mg once daily for days 1-3 to 0.5 mg twice daily for days 4-7, with a final ...
Details concerning the Varenicline 1 mg medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids ...
Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due ...
Inc. Varenicline is a nicotinic receptor partial agonist indicated for use as an aid to smoking cessation treatment. The generic product is supplied as 0.5mg and 1mg tablets. Par’s generic ...
The expanded recall covers all lots of Pfizer's Chantix 0.5mg and 1mg tablets made available ... recall is because the N-nitroso-varenicline in these Chantix tablets may be at or above the FDA ...
Using results from 39 Varenicline studies the team identified a cohort of 10,761 participants that compared the effects of 5,817 patients who had received the maximum dose of 1mg of the drug twice ...
Varenicline, a daily tablet given over a few months, is as effective as vapes and more effective than nicotine replacement gum or patches, NHS England says. The drug, which fights cravings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results